Users Manual Part 1

System Terminology and Navigation 2
30
2 System Terminology and Navigation
Hypoglycemia Low glucose. A lower-than-normal level of
glucose in the blood; generally below
70 mg/dL.
Hypoglycemia unawareness A condition in which a person does not feel or
recognize the symptoms of hypoglycemia.
Infusion site e place on the body where a Pod's cannula is
inserted to deliver insulin.
Insulin on board (IOB) Insulin that is still active (available to lower
glucose) in the body.
Ketoacidosis (Diabetic
ketoacidosis, or DKA)
Diabetic ketoacidosis (DKA) is a serious
condition in which extremely high glucose
and a severe lack of insulin cause the body to
break down fat for energy. e breakdown
of fat releases ketones into the blood and
urine. DKA can take hours or days to develop,
with symptoms that include stomach pain,
nausea, vomiting, fruity breath odor, and rapid
breathing.
Ketones Acidic by-products that result from the
breakdown of fat for energy. e presence of
ketones indicates that the body is using stored fat
(instead of glucose) for energy.
Line of sight How to wear the Pod and CGM on the same
side of the body in a way that the two devices can
"see" one another without your body blocking
their communication.
Manual bolus A bolus amount chosen by you (not calculated
by the SmartBolus Calculator).
Manual Mode Insulin delivery method that delivers insulin
amounts according to the basal rates in your
Basal Program.
Microbolus A small amount of insulin calculated by
SmartAdjust technology delivered automatically
by the Pod every 5 minutes during Automated
Mode.
Omnipod 5 Application
(App)
Soware on the Controller or smartphone that
is the primary user interface of the Omnipod 5
System.
SmartAdjust™ technology Pod soware used to calculate automated insulin
delivery, as oen as every 5 minutes to bring
your glucose to your customized glucose target,
or Target Glucose.